Peggy J. de Vos van Steenwijk

M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells

Moniek Heusinkveld, Peggy J. de Vos van Steenwijk, Renske Goedemans et al. · The Journal of Immunology · 2011 · 365 citations · Full text

Life Sciences, Immunology, Oncology +17

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

Marij J.P. Welters, Gemma G. Kenter, Peggy J. de Vos van Steenwijk et al. · Proceedings of the National Academy of Sciences · 2010 · 238 citations · Full text

Medicine, Immunology, Oncology +17

Prevention of Adhesion to Prosthetic Mesh

Martijne van ’t Riet, Peggy J. de Vos van Steenwijk, F. Bonthuis et al. · Annals of Surgery · 2003 · 198 citations · Full text

Medicine, Surgery, Biocompatibility +16

Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes

Kim E. Kortekaas, Esther Bastiaannet, Helena C. van Doorn et al. · Gynecologic Oncology · 2020 · 131 citations · Full text

Medicine, Oncology, Pathology +17

Tumor‐infiltrating CD14‐positive myeloid cells and CD8‐positive T‐cells prolong survival in patients with cervical carcinoma

Peggy J. de Vos van Steenwijk, Tamara H. Ramwadhdoebé, Renske Goedemans et al. · International Journal of Cancer · 2013 · 126 citations · Full text

Medicine, Immunology, Oncology +16